Literature DB >> 9552056

Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study.

M Degiuli1, M Sasako, A Ponti, T Soldati, F Danese, F Calvo.   

Abstract

PURPOSE: To investigate whether pancreas preservation together with a strict quality-control system could ameliorate the outcome of D2 resections for gastric cancer in Western patients. PATIENTS AND METHODS: Italian patients with potentially curable proven adenocarcinoma of the stomach were registered from nine general and/or university hospitals in the area of Turin, Northern Italy. The study was performed according to the guidelines of the Japanese Research Society for Gastric Cancer (JRSGC). A strict quality-control system was guaranteed by a supervising surgeon of the reference center, who had stayed at the National Cancer Center Hospital, Tokyo, to learn the standard D2 gastrectomy. The standard procedure entailed removal of the level 1 and 2 lymph nodes. During total gastrectomy, the pancreas was preserved according to the Maruyama technique.
RESULTS: Between May 1994 and December 1996, 191 eligible patients were entered onto the study. The mean number of lymph nodes removed was 39. The overall morbidity rate was 20.9%. Surgical complications were observed in 16.7% of patients. Reoperation was necessary in six patients and was always successful. The overall hospital mortality rate was 3.1%; it was higher after total gastrectomy (7.46%) than after distal gastrectomy (0.8%). The average length of hospital stay was 17 days.
CONCLUSION: Given that postoperative morbidity and mortality rates are favorably comparable with those reported after the Western standard gastrectomy, the more extensive Japanese procedure with pancreas preservation can be regarded as a safe radical treatment of gastric cancer for selected Western patients treated in experienced centers.

Entities:  

Mesh:

Year:  1998        PMID: 9552056     DOI: 10.1200/JCO.1998.16.4.1490

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  41 in total

Review 1.  Randomised trials in surgery: problems and possible solutions.

Authors:  Peter McCulloch; Irving Taylor; Mitsuru Sasako; Bryony Lovett; Damian Griffin
Journal:  BMJ       Date:  2002-06-15

2.  Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer.

Authors:  Seth P Harlow; David N Krag; Thomas B Julian; Takamaru Ashikaga; Donald L Weaver; Sheldon A Feldman; V Suzanne Klimberg; Roberto Kusminsky; Frederick L Moffat; R Dirk Noyes; Peter D Beitsch
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

3.  Morbidity and mortality of laparoscopy-assisted gastrectomy with extraperigastric lymph node dissection for gastric cancer.

Authors:  Min-Chan Kim; Ghap-Joong Jung; Hyung-Ho Kim
Journal:  Dig Dis Sci       Date:  2007-01-09       Impact factor: 3.199

4.  Risk factors for operative morbidity and mortality in gastric cancer patients undergoing total gastrectomy.

Authors:  Dao-Jun Gong; Chao-Feng Miao; Qi Bao; Ming Jiang; Li-Fang Zhang; Xiao-Tao Tong; Li Chen
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

5.  Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.

Authors:  F Bozzetti; E Marubini; G Bonfanti; R Miceli; C Piano; L Gennari
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

Review 6.  An evidence-based review of the surgical treatment of gastric adenocarcinoma.

Authors:  Ugwuji N Maduekwe; Sam S Yoon
Journal:  J Gastrointest Surg       Date:  2011-03-12       Impact factor: 3.452

7.  Extended lymphadenectomy in gastric cancer is crucial.

Authors:  Lorenzo Ferri
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

8.  Results of specialization in the surgical treatment of gastric cancer in Peru.

Authors:  Michel Portanova; Fernando Vargas; Emilio Lombardi; Victor Mena; Ramiro Carbajal; Nestor Palacios; Jorge Orrego
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

9.  Identification of a DNA methylation marker that detects the presence of lymph node metastases of gastric cancers.

Authors:  Yasuyuki Shigematsu; Tohru Niwa; Satoshi Yamashita; Hirokazu Taniguchi; Ryoji Kushima; Hitoshi Katai; Seiji Ito; Tetsuya Tsukamoto; Masao Ichinose; Toshikazu Ushijima
Journal:  Oncol Lett       Date:  2012-05-09       Impact factor: 2.967

Review 10.  Gastric cancer: Current status of lymph node dissection.

Authors:  Maurizio Degiuli; Giovanni De Manzoni; Alberto Di Leo; Domenico D'Ugo; Erica Galasso; Daniele Marrelli; Roberto Petrioli; Karol Polom; Franco Roviello; Francesco Santullo; Mario Morino
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.